Unmet needs and treatment of relapsing-remitting multiple sclerosis in saudi arabia: focus on the role of ofatumumab
Treatment-pattern data suggest that some patients with multiple sclerosis (MS) in
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Treatment-pattern data suggest that some patients with multiple sclerosis (MS) in
Background/aim: Multiple sclerosis (MS) is a chronic and debilitating inflammatory autoimmune disease of the central nervous system (CNS) that affects the myelinated axons in the CNS. Incomplete remissions occur…
Background: Multiple sclerosis (MS) is a chronic demyelinating disorder of the central nervous system. Relapsing-Remitting MS (RRMS) is the most common type of MS that accounts
Objective: Fingolimod, a second-line therapy for relapsing-remitting multiple sclerosis, may cause transitory effects on heart rate and atrioventricular conduction that may result in bradycardia and atrioventricular…
certain. The objective of this study was to determine the natural history of relapsing-remitting multiple sclerosis, both treated and untreated, in a real-world setting. Methods: We analyzed relapse ... prolonged…
offering a detailed and comprehensive perspective on the cost-effectiveness of GA for Relapsing-Remitting Multiple Sclerosis (RRMS) from the standpoint of the UK National Health Service
compare the cost–effectiveness of different disease-modifying therapies’ strategies for treatment of relapsing-remitting multiple sclerosis (RRMS) (Figure 1). Methods: A Markov model was developed to assess the cost
behavioral variables in the transtheoretical model of change. Methods: Patients diagnosed with relapsing-remitting multiple sclerosis and being treated with GA for the first time, whether treatment-naïve
flexibility and body balance among RRMS patients. Methods: Twenty-two subjects affected by relapsing-remitting multiple sclerosis (RRMS, EDSS ≤ 6) were randomly divided into 3 groups whose members each performed
objective is to describe basal characteristics and effectiveness of fingolimod in patients with relapsing-remitting multiple sclerosis (RRMS) followed for ≥12 months in routine clinical practice in Spain. Methods…
treated with GA had a much lower rate of decrease in memory function. Thus, relapsing-remitting EAE unfavorably influences short-term memory and early GA treatment partially protects against memory ... with unrelenting…
Objective: It is widely accepted that working memory (WM) impairment has a
Introduction: Quality of life (QoL) has gained increasing importance in multiple sclerosis (MS). We aimed to assess QoL and potentially associated factors such as depression, sexual dysfunction and work absenteeism…
The present study assessed odour threshold, discrimination and identi fi cation in
negative association between human immunodeficiency virus (HIV) Infection and multiple sclerosis (MS) is expected, as MS pathogenesis is triggered by auto-reactive T-cells, which are depressed in case ... benefit from…
Introduction: Once-daily Fingolimod (GilenyaÃ?®, Novartis Pharma AG) is a sphingosine 1
The current research assessed how digital clock drawing test (dCDT) parameters compliment
Acrolein has been implicated as an irritating/exacerbating factor in animal models of relapsing-remitting multiple sclerosis. In animal studies, Apresoline (Hydralazine) has acted as a successful acrolein scavenging…
stem cell transplantation (HSCT) and disease-modifying therapies (DMTs) for the treatment of relapsing-remitting multiple sclerosis (RRMS). Importance Hematopoietic stem cell transplantation (HSCT) represents a…
For authors and organisers
Find the right journal for your paper and submit your manuscript.